SPRO
#3989
Spero Therapeutics, Inc. - Common Stock
1.7 0 USD
-0.22%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-22.02%
Monthly Change
-42.37%
6 month change
-29.17%
Year Change
-31.73%
Previous Close
2.1 8
Open
1.7 0
Low
1.7 0
High
1.7 0
Volume
25
Financials
- Market Capitalization 98.43 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
8.67
Price to sales ratio
2.22
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3958 |  ICCC ImmuCell Corporation - Common Stock | 11.72 USD | +5.78% | +11.73% | +23.11% | +84.86% | 106.03 M USD | ||
| 3976 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.93 USD | +0.17% | -1.33% | +1.72% | -1.50% | 101.87 M USD | ||
| 3992 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.35 USD | +6.15% | +2.49% | +14.81% | +52.86% | 97.39 M USD | ||
| 3994 |  ENLV Enlivex Ltd. - Ordinary Shares | 6.05 USD | -9.30% | +1187.23% | +802.99% | +387.90% | 95.74 M USD |
Frequently asked questions about Spero Therapeutics, Inc. - Common Stock
What is the Spero Therapeutics, Inc. - Common Stock stock price today?
The current price of Spero Therapeutics, Inc. - Common Stock (SPRO) is 1.7. Over the past 24 hours, the stock has changed by -22.02%. Follow the SPRO chart for real-time price dynamics.
What is the stock ticker of Spero Therapeutics, Inc. - Common Stock?
Spero Therapeutics, Inc. - Common Stock trades under the ticker SPRO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Spero Therapeutics, Inc. - Common Stock stock going up?
SPRO has changed by -20.56% over the last week, -42.37% over the last month, and -31.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Spero Therapeutics, Inc. - Common Stock net income for the last quarter?
Spero Therapeutics, Inc. - Common Stock reported net income of -7.2 M for the last quarter. The previous quarter showed 31.52 M, which means net income changed by -122.85%.
How many employees does Spero Therapeutics, Inc. - Common Stock have?
As of the latest available data, Spero Therapeutics, Inc. - Common Stock has 25 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Spero Therapeutics, Inc. - Common Stock stock?
You can buy Spero Therapeutics, Inc. - Common Stock (SPRO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Spero Therapeutics, Inc. - Common Stock stock?
Investing in Spero Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SPRO chart and related analysis on metatrader.com as part of your research.